Phagocytosis by Guinea Pig Alveolar Macrophages

Size: px
Start display at page:

Download "Phagocytosis by Guinea Pig Alveolar Macrophages"

Transcription

1 INFECTION AND IMMUNITY, Apr. 1982, p Vol. 36, No /82/ $02.00/0 Release of Mycoplasma pneumoniae Substances After Phagocytosis by Guinea Pig Alveolar Macrophages M. KIST,* E. JACOBS, AND W. BREDT Institut fur Allgemeine Hygiene und Bakteriologie, Zentrum fur Hygiene, Universitat Freiburg, D-7800 Freiburg, West Germany Received 27 July 1981/Accepted 4 December 1981 Antibody-opsonized Mycoplasma pneumoniae cells with various radioactive markers were sedimented onto monolayers of guinea pig alveolar macrophages (AM). After 2 h of incubation, about 50% of the activity of [3H]palmitate-labeled mycoplasmas was associated with AM. Nonspecific attachment of the opsonized mycoplasmas to AM-free plastic surface areas was negligible. The occurrence of phagocytosis was proven by electron microscopy and monitoring of AM surfacebound antigen by 125I-labeled F(ab)2 fragments. The activity of [3H]palmitic acidlabeled mycoplasmas was only slowly released into the supernatant. About 55% of the activity remained AM-associated up to 70 h after phagocytosis. After phagocytosis of [3H]thymidine-labeled cells, about 70% of the radioactivity found in the supernatant was released within 8 h. More than 80% of this activity was non-precipitable by trichloracetic acid. 3H-amino acid-labeled protein was released to 50% within 8 h. Supernatants and AM were tested for M. pneumoniae antigen with enzyme-linked immunosorbent assay. Considerable amounts of antigenically active material could be found in the supernatant within 8 h. This antigen was totally inactivated by heat (80 C). Trypsin treatment (1 mg/ml, 10 min) reduced the antigenicity by 80%. The results suggest a selective release of microbial material after phagocytosis. Alveolar macrophages (AM) are the first line of cellular defense against infection from Mycoplasma pneumoniae. The interaction of these phagocytes (6, 8, 12) or of macrophages of other origins (1, 5, 7, 9, 10, 14) with mycoplasmas has been studied by several authors, but effective phagocytosis has only been observed after opsonization (5, 6, 8, 9, 10, 12, 14). However, little is known about the fate of the ingested microbial substances. The release of [3H]thymidine was used as marker of cellular destruction (9), but no sufficient data are available on other mycoplasmal components, such as membrane glycolipids or proteins. Even less is known about the biological activity of such native or modified molecules released by the macrophage. These molecules may still be able to activate complement (2, 3), react with antibody, or attach to host cell membranes. This study describes the characteristics of a phagocytosis system using guinea pig AM and M. pneumoniae. MATERIALS AND METHODS Mycoplasmas. M. pneumoniae strain FH was grown in Roux bottles in 100-ml Hayflicks medium containing 1,000 U/ml of penicillin, 0.05% thallium acetate, and 1% glucose. Radioactive substances were added according to the experimental schedule. A frozen stock inoculum (-70 C) containing about 108 colony-forming units per ml was used for each culture. After 48 h at 37 C, the glass adherent mycoplasmas were washed four times with 5 ml of cold, sterile phosphate-buffered saline (PBS), ph 7.2, and harvested into 3 ml of tissue culture medium (TCM) as described below. The suspension was diluted to an optical density of 0.15 at 660 nm before being used. Radioactive labeling of mycoplasma cells. For experiments with labeled M. pneumoniae cells, 50,uCi of [3H]palmitic acid or 150,uCi of [6_3H]thymidine was added to 100 ml of the growth medium before incubation. The mycoplasmas were harvested as previously described and tested for specific activity. For protein labeling, the glass adherent mycoplasmas of one Roux bottle were harvested into 1 ml of amino acid-free TCM containing 2% horse serum and substituted with 0.1,uCi of a 3H-amino acid mixture or 1.Ci with 357 [14C]methionine, respectively. After 4 h of incubation at 37 C, the mycoplasma cells were centrifuged and washed three times with PBS. Radioactive amino acids not bound to the proteins of mycoplasma cells were separated by passage of the suspension through a Sephadex G-25 column (9.1-ml bed volume). Preparation and labeling of anti-m. pneumoniae F(ab)2 fragments with "2I. Rabbit anti-m. pneumoniae immunoglobulin G (IgG; 50 mg) purified by gel filtration was digested with 3 mg of pepsin in 0.1 M sodium acetate buffer, ph The digestion products were gel filtrated (Sephacryl S 300), and the antibody activity of the F(ab)2 fraction was determined in an indirect immunofluorescent assay on glass-grown M. pneumoniae cells. The absence of Fc fragments was proven

2 358 KIST, JACOBS, AND BREDT by the negative complement fixation test with M. pneumoniae as antigen. F(ab)2 fragments (0.5 mg) were iodinated with 0.5 mci of carrier-free 125I (Eidgenossisches Institut fur Reaktorforschung, Wurenlingen, Switzerland) by using the chloramin T method (11). Unbound 1251 was removed by gel filtration on Bio-Gel P10 (1 by 30 cm). The specific antibody activity of iodinated F(ab)2 fragments was again tested by immunofluorescence on M. pneumoniae and the absence of binding onto AM monolayers. AM. The lungs of anaesthesized guinea pigs were washed four times with 20 ml of cold TCM containing antibiotics. The cells were centrifuged in siliconized vials for 10 min at 300 x g, resuspended in 10 ml of TCM, and adjusted to 106 cells per ml. Samples of this suspension (2 ml) were put into plastic petri dishes (Nuncolon, Nunc, Denmark; 35 by 8 mm) and allowed to settle at 37 C in a CO2 atmosphere. After 2 h the cultures were vigorously washed four times with PBS to remove nonadherent cells (about 40%). These monolayers were incubated for 15 to 20 h at 37 C in a CO2 atmosphere before use and considered to be AM. The viability of the cultures was monitored by measuring the lactate dehydrogenase concentration of the supernatant and by using the trypan blue exclusion test. Chemicals and media. Medium 199 (Flow Laboratories, Inc., Rockville, Md.) with glutamine and sodium bicarbonate, and 2 mm N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) was used as TCM. The 3H-labeled substances were obtained from Amersham-Buchler (Braunschweig, Germany). As coating buffer for enzyme-linked immunosorbent assay, a sodium carbonate-bicarbonate buffer (ph 9.6) was used. As a substrate buffer, a diethanolamin buffer (ph 9.8) was used (97 ml of diethanolamin, 100 mg of MgCl2 6H2O, and 800 ml of distilled water). Cytochalasin B, trypsin, and trypsin inhibitor were purchased from Serva (Heidelberg, West Germany). Phagocytosis. The M. pneumoniae suspension was opsonized by rabbit anti-m. pneumoniae antiserum in a final concentration of 1:200 (15 min at 37 C) with intermittent mixing. Amounts of 900 RI each of these suspensions were centrifuged onto AM monolayers (300 x g for 10 min at room temperature). After 2 h of incubation at 37 C, the cultures were washed four times with 2 ml of sterile PBS and refilled with 2 ml of TCM. This was termed zero hour. Electron microscopy. After 2 h of phagocytosis, AM were washed three times with PBS (2 ml), fixed in situ with 3% glutaraldehyde in PBS (ph 7.2) for 30 min on ice, and then treated with 1% OS04 in 0.1 M cacodylate buffer (ph 7.2) for 2 h. During dehydration with increasing concentrations of ethanol, the cultures were prestained with 0.5% uranyl acetate and 1% phosphotungstic acid at the 70% ethanol step. After centrifugation (800 x g for 10 min), the pellet was embedded in Epon. Sections were cut on the LKB microtome, stained with uranyl acetate and lead citrate, and examined in a Siemens Elmiscop 102. M. pneumoniae antigen bound onto AM surfaces. Phagocytosis of M. pneumoniae was performed as previously described. At various times after the 2-h phagocytosis period, the cultures were thoroughly washed with PBS. Diluted anti-m. pneumoniae F(ab)2 fragments (100,l) labeled with 1251 were added and the cultures were incubated for 20 min at room temperature. Unbound F(ab)2 fragments were removed by washing them with PBS, and the remaining radioactivity was determined. The total amount of AM-associated M. pneumoniae could be estimated by simultaneous [3H]palmitic acid labeling of the mycoplasma cells. AM monolayers without M. pneumoniae were used as controls. Experiments were done in triplicate. Detection of antigen. An enzyme-linked immunosorbent assay was used for the detection of M. pneumoniae antigen. Enzyme-linked immunosorbent assay microplates (Dynatech Laboratories, Nuirtingen, West Germany) were coated by putting 200,u of coating buffer containing 100,ug/ml anti-m. pneumoniae IgG purified by gel filtration (Sephacryl S 300, Pharmacia, Inc., Freiburg, West Germany) in each well. The plates were incubated at 4 C for 24 h and washed with PBS containing 0.05% Tween 20. The samples diluted in PBS-Tween buffer containing 0.5% bovine serum albumen put in the wells and incubated overnight at 4 C. The plates were then washed as described above and treated with the IgG-phosphatase conjugate (200,ug protein per ml). After reaction (2 h at 37 C and then 4 h at 4 C), the unbound conjugate was removed by washing, and the substrate p-nitrophenylphosphate (Boehringer Mannheim Corp.; 1 mg/ml) was added. After 30 min at room temperature, the plate was read at 405 nm in a Dynatech Multiscan. Buffer, conjugate, and standard mycoplasma suspensions were used as appropriate controls. IgG conjugate. The isolated IgG fraction was coupled with alkaline phosphatase by the modified method of Avrameas as described by Clark and Adams (4). Antigen treatment by heat and trypsin. Four hours after phagocytosis, supernatants and AM (sonicated three times for 1 min, power 4, Branson Sonifier Cell Disrupter B15; Branson Instruments Co.) were heated at different temperatures for 10 min or treated with trypsin (1 mg of trypsin per ml for 10 min at 37 C). RESULTS INFECT. IMMUN. Characteristics of the phagocytosis system. About 50 to 75% of the harvested alveolar cells became adherent after 2 h of cultivation, and 90% of them excluded trypan blue. During the phagocytosis experiments, the viability decreased, usually within 48 h, to about 70% of the adherent cells. Additionally, the number of glass-attached AM was reduced to about 80% after 20 h and about 70% after 48 h. The effectiveness of the phagocytosis system was tested with [3H]palmitic acid-labeled mycoplasmas. After centrifugation, incubation (2 h), and washing, about 50% of the activity was found to be associated with the AM monolayer (Fig. 1A). An additional complement treatment (10% guinea pig serum) in an experiment with [3H]thymidinelabeled mycoplasmas removed only a minor part of this AM-associated activity, suggesting that most of the mycoplasmas were internalized or tightly bound to the macrophage surface. Electron microscopy. Numerous mycoplasmas were found in phagocytic vacuoles (Fig. 2). In

3 VOL. 36, 1982 M. PNEUMONIAE RELEASE AFTER AM PHAGOCYTOSIS 359 C- _20 EL 10 A B 3H- PALMITATE Ic ac ie z n 4 e i c c 1U ou 11 Time after phagecytesi (hairs) FIG. 1. Phagocytosis of [3H]palmitic acid-labeled M. pneumoniae by guinea pig AM. The results of two experiments (I and II) are shown. (A) Characteristics of the phagocytosis system. Symbols: a, total amount of radioactivity applied per petri dish; b, AM-associated activity after 2 h of phagocytosis; c, non-specifically bound activity in control dishes without macrophages. (B) Release of [3H]palmitic acid-labeled substances. Sampling of supernatant started after 2 h of phagocytosis (not included in time) and removal of mycoplasma suspension. The supernatant activity was plotted cumulatively. some of the phagocytized mycoplasmas, typical structural elements, e.g., the tip structure, remained visible, and some other organisms showed peripheral chromatin clumping or the beginning of degradation. The phagosomes increased in size during time, probably by fusion with surrounding lysosomes. Disappearance of M. pneumoniae antigen from AM surface during phagocytosis. 125I-labeled F(ab)2 fragments of anti- M. pneumoniae IgG were used to detect antigenic material on the macrophage surface. The F(ab)2 labeling of surface-bound antigenicity is possible only after the initial 2-h phagocytosis period has ended and the supernatant of opsonized M. pneumoniae cells has been removed. At this time much of the mycoplasma material has already been internalized, and consequently, the antigen exposed on the macrophage surface at this particular moment is only a fraction of the total macrophageassociated antigen. The results are demonstrated in Table 1. The total amount of mycoplasma material (inside and outside the macrophage) is represented by the 3H counts of the palmitic acid-labeled mycoplasmas. The activity of 1251 represents only the mycoplasma antigen bound to the macrophage surface. The data show a considerable reduction of this material to about 15% (1251) after 22 h, whereas the total amount of AM-associated mycoplasma material apparently drops only to 70% (3H). In the presence of cytochalasin B, a different pattern is seen. The AM-associated activity is reduced to a comparable level (about 83%), but about 40% of the initial surface-bound antigenicity is still detectable after 22 h. Furthermore, the proportion of antigen remaining at the surface is apparently much higher under the influence of the inhibitor, as indicated by a lower 3H/125I ratio (nine versus four) at time 0. The results suggest an effective inhibition of phagocytosis by cytochalasin B and continuous internalization under normal conditions. Release of [3H]thymidine-labeled substances. After phagocytosis of [3H]thymidine-labeled mycoplasmas, most of the label was found in the supernatant within a few hours (Fig. 3). Of the activity released within 50 h, about 65 to 75% was detected within the first 8 h. Of this activity, 84 to 93% was not precipitable by 10% trichloracetic acid. When cytochalasin B (10,ug per ml) was added to prevent phagocytosis, the release of 3H-labeled material was reduced by about 20 to 40%. Release of [3H]palmitic acid-labeled substances. In contrast to the thymidine experiments, the activity of the [3H]palmitic acid-labeled mycoplasmas was only slowly released into the supernatant after phagocytosis (Fig. 1B). About 55% of the radioactive material remained associated with the adherent AM for as long as 70 h. After centrifugation of the supernatants at 12,000 x g (5 min), 14 to 28% of the activity was found in the pellet, probably representing detached AM. Release of 3H-amino acid-labeled substances. The release pattern of amino acid-labeled mycoplasmas was comparable to that of thymidine. Within the first 8 h, about 50% of the activity was found in the supernatant (Fig. 4). After 20 h, only 20 to 28% of the total activity was still bound to the macrophages. Antigen detection. Supernatants and residual AM monolayers were tested for M. pneumoniae antigen. The occurrence of antigenically active material in the supernatant is shown in Fig. 5. Apparently most (about 80%) of the detectable material was released within 8 h. Characteristics of released and AM-associated antigen. The antigenic activity found in the supernatant (4 h) was destroyed by being heated at 90 C for 10 min. Additional experiments showed that the inactivation began at 54 C and was completed at 80 C. When the activity of the AMassociated antigen (4 h) was tested under comparable conditions, antigenicity was reduced to 10% at 80 C, and no further reduction was seen at 100 C. This corresponds with the results obtained on sonicated suspensions of whole M. pneumoniae cells. The antigenicity of the supernatant was reduced to 20% by treatment with 1 mg of trypsin per ml (10 min at 37 C). Furthermore, ammonium sulfate in a concentration of

4 360 KIST, JACOBS, AND BREDT Mf~ ~ ~ ~ ~ ~ *' 0s. * R '..!.,.: :....:.c M *C.r.. k ; Mp'''."* : F INFECT. IMMUN. z : '':i :: '. f.. e N..:... s*e\ 'I:.!tR:!... :S..S... S$; a: :; mk: *e.e FIG. 2. Electron micrograph of AM after 2 h of phagocytosis of opsonized M. pneumoniae (Mp). Abbreviations: CM, cytoplasma membrane; N, nucleus. Bar = 1,.m. 80% (wt/vol) precipitated 86% of the antigenic activity. DISCUSSION Quantitative studies of phagocytosis systems are often hampered because some of the microorganisms are not ingested, thereby influencing the results of viable counts and other parameters. This problem is even more complicated with mycoplasmas, especially M. pneumoniae. Their ingestion cannot be monitored sufficiently by light microscopy, and furthermore, they stick effectively to those areas of the plastic surface which are not covered by the macrophages. Four systems are conceivable for maximal phagocytosis of M. pneumoniae: (i) phagocytosis with both reaction partners in suspension (8); (ii) macrophages sedimented onto sheets of glass-grown mycoplasmas (1); (iii) monolayers of macrophages infected with mycoplasmas which are subsequently opsonized (5, 6, 8, 9, 10, 12); and (iv) monolayers of macrophages onto which opsonized mycoplasmas are sedimented. Preliminary experiments suggested the use of the last method, mainly because the portion of mycoplasmas attaching "unspecifically" could be kept to a minimum. At the same time the macrophages could be precultivated for longer times, reducing the number of nonphagocytic cells to a minimum. On the other hand, opsonized mycoplasmas often form small aggregates and are therefore more difficult to quantitate TABLE 1. Effect of cytochalasin B on internalization of M. pneumoniae by AM No inhibitor Cytochalasin B (10 pkg/ml) Controla Time (h) Mycoplasma AM- Mycoplasma after end of AM-associated Myconlasma AM- Mycop AM without phagocytosis mycoplasmas mycoplasmas period (3H cpm) AM surface mycoplasmas AM surface (1251 cpm) pefiod ('H cpm) ~~~(1251 cpm) (3H cpm) (125i cpm) 0 14,335 ± 325b 1,578 ± 96 8,784 ± 278 2,100 ± ± ,179 ± 537 1,210 ± 95 6,762 ± 141 1,747 ± ± ,048 ± ± 24 7,313 ± ± ± 53 a AM without mycoplasmas treated with F (ab)2 fragments. b Mean value cpm ± SD.

5 VOL. 36, Time after phagocytosis (hours) FIG. 3. Release of [3H]thymidine-labeled substances from M. pneumoniae after phagocytosis by guinea pig AM. The phagocytosis took 2 h, and the time of release began after removal of the mycoplasma suspension. The results of two experiments (I and II) are shown. (this property was apparently not of major importance in this study). The data obtained in our experiments suggest a sufficient uptake of opsonized mycoplasmas by the macrophages. Electron microscopy and staining with fluorescent dyes (unpublished observations) show an internalization even of aggregates of considerable size. The number of M. pneumoniae cells found outside the macrophages after the 2-h phagocytosis period was small enough not to influence the results significantly. Even these cells, mostly aggregates, were probably taken up by the phagocytes during the following hours of incubation, as suggested by the disappearance of most of the mycoplasma antigen from the macrophage surface. During the first hours of phagocytosis, mycoplasma material may be released in two ways: (i) by lysis of microorganisms which are attached to the phagocyte surface or (ii) by release of such substances from within the phagocyte. The first way is probably more efficient in mycoplasmas than in other bacteria because the lack of a cell wall permits a direct attack of excreted lysosomal enzymes on the mycoplasma membrane. The considerable amount of thymidine label found in the supernatant, even in the presence of cytochalasin B, suggests a certain degree of such extracellular lysis. However, the inhibitor itself is apparently triggering an increased release of lysosomal enzymes (13, 15, 16) so that the data are probably not completely representative of the unmodified phagocytosis. The results with labeled thymidine and amino M. PNEUMONIAE RELEASE AFTER AM PHAGOCYTOSIS 361 acids during the first hours of phagocytosis suggest a relatively fast release, mainly of cytoplasmic material. A different pattern was observed with the palmitate label. Apparently, the mycoplasma lipids are retained within the macrophage for a much longer time. They may be stored there in the form of intact mycoplasma substance, as suggested by the antigen content of the macrophages, or the labeled fatty acid could possibly be used by the phagocyte for its own lipid synthesis. The substances released into the supernatant in the hours after phagocytosis are at least partially mycoplasma antigens with properties which indicate their protein nature. They are apparently not degraded by the action of lysosomal enzymes and are therefore immediately available for further biological interactions with the humoral and cellular factors of the host. The fate and further role of the substances retained in the macrophage for the time of observation is unknown. The few data available suggest that a considerable part of these materials are of nonprotein nature, consisting possibly of membrane lipids, but they may also contain some membrane proteins, which at least partly may be retained within the phagocytic cell. The fast or delayed release of products of the phagocytic process could have some biological importance for the interaction between parasite and host in the early stages and in the sequelae of infectious diseases. Besides being spread X.20 c E CT 1X0 A a*b Zeit mach Phagozytose (Stunden) FIG. 4. Release of 3H-amino acid mixture and [14C]methionine-labeled substances after 2 h of phagocytosis. Time of release began after removal of mycoplasma suspension. (A) Characteristics of macrophages. Symbols: a, AM-associated activity after 2 h of phagocytosis; b, AM-associated activity after 20 h. (B) Characteristics of the supernatant showing release of 3H-amino acids (I) and [14C]methionine- (II) labeled substances. Cumulative plotting of the supernatant activity was done.

6 362 KIST, JACOBS, AND BREDT 3.0 ;, i M._ go g::::~~d~~.:. A Time after phagocytosis (hours) FIG. 5. Release of M. pneumoniae antigen from AM after 2 h of phagocytosis. Cumulative plotting was done, and the amount of antigen was measured by enzyme-linked immunosorbent assay. Symbols: 0, supernatant; 0, supernatant heated at 90 C for 10 min; A, control (release from dishes treated with M. pneumoniae suspension, but without AM). Mean values were calculated from triplicate tests. The standard deviation was 7 to 10%. throughout the tissues of the host, these substances may act as immunogenic stimuli, reacting with effector systems such as complement (2, 3), and they could be toxic for the host cell membraneb, alter the surface of the host cell, or interfere with immunological reactions. They therefore certainly deserve further investigation. LITERATURE CITED 1. Bredt, W Phagocytosis by macrophages of Mycoplasma pneumoniae after opsonization by complement. Infect. Immun. 12: Bredt, W., and D. Bitter-Suermann Interactions INFECT. IMMUN. between Mycoplasma pneumoniae and guinea pig complement. Infect. Immun. 11: Bredt, W., B. Wellek, H. Brunner, and M. Loos Interactions between Mycoplasma pneumoniae and the first component of complement. Infect. Immun. 15: Clark, M. F., and A. N. Adams Characteristics of the microplate method of enzyme-linked immunosorbent assay for the detection of plant viruses. J. Gen. Virol. 34: Cole, B. C., and J. R. Ward Interaction of Mycoplasma arthritidis and other mycoplasmas with murine peritoneal macrophages. Infect. Immun. 7: Erb, P., and W. Bredt Interaction of Mycoplasma pneumoniae with alveolar macrophages: viability of adherent and ingested mycoplasmas. Infect. Immun. 25: Howard, C. J., and G. Taylor Variation in the virulence of strains of Mycoplasma pulmonis related to susceptibility to killing by macrophages in vivo. J. Gen. Microbiol. 114: Howard, C. J., G. Taylor, J. Collins, and R. N. Gourlay Interaction of Mycoplasma dispar and Mycoplasma agalactiae subsp. bovis with bovine alveolar macrophages and bovine lacteal polymorphonuclear leucocytes. Infect. Immun. 14: Jones, T. C., and J. G. Hirsch The interaction in vitro of Mycoplasma pulmonis with mouse peritoneal macrophages and L-cells. J. Exp. Med. 133: Jones, T. C., S. Yeh, and J. G. Hirsch Studies on attachment and ingestion phases of phagocytosis of Mycoplasma pulmonis by mouse peritoneal macrophages. Proc. Soc. Exp. Biol. Med. 139: McConahey, P. J., and F. J. Dixon A method of trace iodination of proteins for immunologic studies. Int. Arch. Allergy 29: Powell, D. A., and W. A. Clyde, Jr Opsoninreversible resistance of Mycoplasma pneumoniae to in vitro phagocytosis by alveolar macrophages. Infect. Immun. 11: Sorber, W. A Effect of complement fixation on the release of lysosomal enzymes from rabbit alveolar macrophages. Infect. Immun. 19: Taylor, G., and C. J. Howard Interaction of Mycoplasma pulmonis with mouse peritoneal macrophages and polymorphonuclear leucocytes. J. Med. Microbiol. 13: Temple, A., G. Loewi, P. Davies, and A. Howard Cytotoxicity of immune guinea-pig cells. Immunology 24: Zurier, R. B., S. Hoffstein, and G. Weissmann Cytochalasin B: effect on lysosomal enzyme release from human leukocytes. Proc. Nat. Acad. Sci. U.S.A. 70:

CHAPTER 4 IMMUNOLOGICAL TECHNIQUES

CHAPTER 4 IMMUNOLOGICAL TECHNIQUES CHAPTER 4 IMMUNOLOGICAL TECHNIQUES Nitroblue Tetrazolium Chloride (NBT) Reduction test NBT reduction test was evaluated by employing the method described by Hudson and Hay,1989 based upon principle that

More information

Third line of Defense

Third line of Defense Chapter 15 Specific Immunity and Immunization Topics -3 rd of Defense - B cells - T cells - Specific Immunities Third line of Defense Specific immunity is a complex interaction of immune cells (leukocytes)

More information

Instructions for Use. APO-AB Annexin V-Biotin Apoptosis Detection Kit 100 tests

Instructions for Use. APO-AB Annexin V-Biotin Apoptosis Detection Kit 100 tests 3URGXFW,QIRUPDWLRQ Sigma TACS Annexin V Apoptosis Detection Kits Instructions for Use APO-AB Annexin V-Biotin Apoptosis Detection Kit 100 tests For Research Use Only. Not for use in diagnostic procedures.

More information

Instructions. Fuse-It-Color. Overview. Specifications

Instructions. Fuse-It-Color. Overview. Specifications Membrane fusion is a novel and highly superior method for incorporating various molecules and particles into mammalian cells. Cargo-specific liposomal carriers are able to attach and rapidly fuse with

More information

THE BRITISH JOURN OF VOL. LII OCTOBER, 1971 NO. 5 EXPERIMENTAL PATHOLOGY DISAGGREGATED CELLS OF THE TRANSMISSIBLE VENEREAL TUMOUR OF THE DOG

THE BRITISH JOURN OF VOL. LII OCTOBER, 1971 NO. 5 EXPERIMENTAL PATHOLOGY DISAGGREGATED CELLS OF THE TRANSMISSIBLE VENEREAL TUMOUR OF THE DOG Vol. Lll, No. 4 (August, 1971) was issued 2.9.71. THE BRITISH JOURN OF EXPERIMENTAL PATHOLOGY VOL. LII OCTOBER, 1971 NO. 5 A PHENOMENON RESEMBLING OPSONIC ADHERENCE SHOWN BY DISAGGREGATED CELLS OF THE

More information

IMMUNOLOGIC REACTIVITY IN HUMAN BREAST CANCER AGAINST CULTURED HUMAN BREAST TUMOR CELLS

IMMUNOLOGIC REACTIVITY IN HUMAN BREAST CANCER AGAINST CULTURED HUMAN BREAST TUMOR CELLS 22 IMMUNOLOGIC REACTIVITY IN HUMAN BREAST CANCER AGAINST CULTURED HUMAN BREAST TUMOR CELLS Michael P. Lerner*, J. H. Anglin, Peggy L. Munson, Peggy J. Riggs, Nancy E. Manning, and Robert E. Nordquist Departments

More information

EVALUATION OF THE EFFECTIVENESS OF A 7% ACCELERATED HYDROGEN PEROXIDE-BASED FORMULATION AGAINST CANINE PARVOVIRUS

EVALUATION OF THE EFFECTIVENESS OF A 7% ACCELERATED HYDROGEN PEROXIDE-BASED FORMULATION AGAINST CANINE PARVOVIRUS Final report submitted to Virox Technologies, Inc. EVALUATION OF THE EFFECTIVENESS OF A 7% ACCELERATED HYDROGEN PEROXIDE-BASED FORMULATION AGAINST CANINE PARVOVIRUS Syed A. Sattar, M.Sc., Dip. Bact., M.S.,

More information

Procine sphingomyelin ELISA Kit

Procine sphingomyelin ELISA Kit Procine sphingomyelin ELISA Kit For the quantitative in vitro determination of Procine sphingomyelin concentrations in serum - plasma - celiac fluid - tissue homogenate - body fluid FOR LABORATORY RESEARCH

More information

Instructions. Fuse-It-mRNA easy. Shipping and Storage. Overview. Kit Contents. Specifications. Note: Important Guidelines

Instructions. Fuse-It-mRNA easy. Shipping and Storage. Overview. Kit Contents. Specifications. Note: Important Guidelines Membrane fusion is a highly efficient method for transfecting various molecules and particles into mammalian cells, even into sensitive and primary cells. The Fuse-It reagents are cargo-specific liposomal

More information

BY F. BROWN, B. CARTWRIGHT AND DOREEN L. STEWART Research Institute (Animal Virus Diseases), Pirbright, Surrey. (Received 22 August 1962) SUMMARY

BY F. BROWN, B. CARTWRIGHT AND DOREEN L. STEWART Research Institute (Animal Virus Diseases), Pirbright, Surrey. (Received 22 August 1962) SUMMARY J. gen. Microbial. (1963), 31, 179186 Prinied in Great Britain 179 The Effect of Various Inactivating Agents on the Viral and Ribonucleic Acid Infectivities of FootandMouth Disease Virus and on its Attachment

More information

IN VITRO CELLULAR RESPONSES TO AUTOLOGOUS TUMOR EXTRACT DETECTED BY INHIBITION OF MACROPHAGE MIGRATION*1

IN VITRO CELLULAR RESPONSES TO AUTOLOGOUS TUMOR EXTRACT DETECTED BY INHIBITION OF MACROPHAGE MIGRATION*1 [Gann, 66, 167-174; April, 1975] IN VITRO CELLULAR RESPONSES TO AUTOLOGOUS TUMOR EXTRACT DETECTED BY INHIBITION OF MACROPHAGE MIGRATION*1 Tsuyoshi AKIYOSHI, Akira HATA, and Hideo TSUJI Department of Surgery,

More information

Secondary fluorescent staining of virus antigens by rheumatoid factor and fluorescein-conjugated anti-lgm

Secondary fluorescent staining of virus antigens by rheumatoid factor and fluorescein-conjugated anti-lgm Ann. rheum. Dis. (1973), 32, 53 Secondary fluorescent staining of virus antigens by rheumatoid factor and fluorescein-conjugated anti-lgm P. V. SHIRODARIA, K. B. FRASER, AND F. STANFORD From the Department

More information

What is the immune system? Types of Immunity. Pasteur and rabies vaccine. Historical Role of smallpox. Recognition Response

What is the immune system? Types of Immunity. Pasteur and rabies vaccine. Historical Role of smallpox. Recognition Response Recognition Response Effector memory What is the immune system? Types of Immunity Innate Adaptive Anergy: : no response Harmful response: Autoimmunity Historical Role of smallpox Pasteur and rabies vaccine

More information

Biological Consulting Services

Biological Consulting Services Biological Consulting Services of North Florida/ Inc. May 13, 2009 Aphex BioCleanse Systems, Inc. Dear Sirs, We have completed antimicrobial efficacy study on the supplied Multi-Purpose Solution. The testing

More information

BACTERIAL PATHOGENESIS

BACTERIAL PATHOGENESIS BACTERIAL PATHOGENESIS A pathogen is a microorganism that is able to cause disease. Pathogenicity is the ability to produce disease in a host organism. Virulence a term which refers to the degree of pathogenicity

More information

From the Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York 10021

From the Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York 10021 Published Online: 1 February, 1981 Supp Info: http://doi.org/10.1084/jem.153.2.398 Downloaded from jem.rupress.org on April 7, 2018 INTERACTION OF THE LEGIONNAIRES' DISEASE BACTERIUM (LEGIONELLA PNEUMOPHILA)

More information

Third line of Defense. Topic 8 Specific Immunity (adaptive) (18) 3 rd Line = Prophylaxis via Immunization!

Third line of Defense. Topic 8 Specific Immunity (adaptive) (18) 3 rd Line = Prophylaxis via Immunization! Topic 8 Specific Immunity (adaptive) (18) Topics - 3 rd Line of Defense - B cells - T cells - Specific Immunities 1 3 rd Line = Prophylaxis via Immunization! (a) A painting of Edward Jenner depicts a cow

More information

Chlorphenesin: an Antigen-Associated Immunosuppressant

Chlorphenesin: an Antigen-Associated Immunosuppressant INFECTION AND IMMUNITY, JUlY 197, p. 6-64 Vol. 2, No. 1 Copyright 197 American Society for Microbiology Printed in U.S.A. Chlorphenesin: an Antigen-Associated Immunosuppressant H. Y. WHANG AND E. NETER

More information

Human Apolipoprotein A1 EIA Kit

Human Apolipoprotein A1 EIA Kit A helping hand for your research Product Manual Human Apolipoprotein A1 EIA Kit Catalog Number: 83901 96 assays 1 Table of Content Product Description 3 Assay Principle 3 Kit Components 3 Storage 4 Reagent

More information

Chapter 14. In Vitro Measurement of Phagocytosis and Killing of Cryptococcus neoformans by Macrophages. André Moraes Nicola and Arturo Casadevall

Chapter 14. In Vitro Measurement of Phagocytosis and Killing of Cryptococcus neoformans by Macrophages. André Moraes Nicola and Arturo Casadevall Chapter 14 In Vitro Measurement of Phagocytosis and Killing of Cryptococcus neoformans by Macrophages André Moraes Nicola and Arturo Casadevall Abstract Macrophages are pivotal cells in immunity against

More information

Mitochondrial Trifunctional Protein (TFP) Protein Quantity Microplate Assay Kit

Mitochondrial Trifunctional Protein (TFP) Protein Quantity Microplate Assay Kit PROTOCOL Mitochondrial Trifunctional Protein (TFP) Protein Quantity Microplate Assay Kit DESCRIPTION Mitochondrial Trifunctional Protein (TFP) Protein Quantity Microplate Assay Kit Sufficient materials

More information

MTS assay in A549 cells

MTS assay in A549 cells Project: VIGO MTS assay in A549 cells Detection of cell viability/activity AUTHORED BY: DATE: Cordula Hirsch 20.01.2014 REVIEWED BY: DATE: Harald Krug 10.04.2014 APPROVED BY: DATE: DOCUMENT HISTORY Effective

More information

Total Histone H3 Acetylation Detection Fast Kit (Colorimetric)

Total Histone H3 Acetylation Detection Fast Kit (Colorimetric) Total Histone H3 Acetylation Detection Fast Kit (Colorimetric) Catalog Number KA1538 48 assays Version: 02 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use...

More information

EXPERIMENTAL SALMONELLOSIS

EXPERIMENTAL SALMONELLOSIS EXPERIMENTAL SALMONELLOSIS INTRACELLULAR GROWTH OF Salmonella enteritidis INGESTED IN MONONUCLEAR PHAGOCYTES OF MICE, AND CELLULAR BASIS OF IMMUNITY SUSUMU MITSUHASHI, ICHIEI SATO, AND TOKUMITSU TANAKA

More information

Growth of Cryptococcus neoformans Within Human Macrophages In Vitro

Growth of Cryptococcus neoformans Within Human Macrophages In Vitro INFECTlON AND IMMUNrry, Feb. 1973, p..231-236 Copyright 0 1973 American Society for Microbiology Vol. 7, No. 2 Printed in U.S.A. Growth of Cryptococcus neoformans Within Human Macrophages In Vitro RICHARD

More information

TRACP & ALP Assay Kit

TRACP & ALP Assay Kit Cat. # MK301 For Research Use TRACP & ALP Assay Kit Product Manual Table of Contents I. Description...3 II. III. IV. Introduction...3 Components...4 Materials Required but not Provided...4 V. Storage...4

More information

Electron Microscopy of Small Cells: Mycoplasma hominis

Electron Microscopy of Small Cells: Mycoplasma hominis JOURNAL of BAcTRiowOY, Dc. 1969, p. 1402-1408 Copyright 0 1969 American Society for Microbiology Vol. 100, No. 3 Printed In U.S.A. NOTES Electron Microscopy of Small Cells: Mycoplasma hominis JACK MANILOFF

More information

Ultrastructure of Mycoplasmatales Virus laidlawii x

Ultrastructure of Mycoplasmatales Virus laidlawii x J. gen. Virol. (1972), I6, 215-22I Printed in Great Britain 2I 5 Ultrastructure of Mycoplasmatales Virus laidlawii x By JUDY BRUCE, R. N. GOURLAY, AND D. J. GARWES R. HULL* Agricultural Research Council,

More information

CONTENTS. STUDY DESIGN METHODS ELISA protocol for quantitation of mite (Dermatophagoides spp.) Der p 1 or Der f 1

CONTENTS. STUDY DESIGN METHODS ELISA protocol for quantitation of mite (Dermatophagoides spp.) Der p 1 or Der f 1 CONTENTS STUDY DESIGN METHODS ELISA protocol for quantitation of mite (Dermatophagoides spp.) Der p 1 or Der f 1 ELISA protocol for mite (Dermatophagoides spp.) Group 2 ALLERGENS RESULTS (SUMMARY) TABLE

More information

For questions 1-5, match the following with their correct descriptions. (24-39) A. Class I B. Class II C. Class III D. TH1 E. TH2

For questions 1-5, match the following with their correct descriptions. (24-39) A. Class I B. Class II C. Class III D. TH1 E. TH2 Questions Made by SI ATTENDEES!! :) Page 1 of 6 Student-Made Practice Exam Activity All questions, answers, and slide numbers are based off of Monday s SI activity, where students/attendees created possible

More information

Aac Reagent Set ELISA for the detection of Acidovorax avenae subsp. citrulli Catalog number: SRA 14800

Aac Reagent Set ELISA for the detection of Acidovorax avenae subsp. citrulli Catalog number: SRA 14800 List of contents Lot number Aac Reagent Set Item 96 wells 500 wells 1000 wells 5000 wells Capture antibody 0.150 ml 0.275 ml 0.525 ml 2.525 ml Alkaline phosphatase enzyme conjugate 0.150 ml 0.275 ml 0.525

More information

Europium Labeling Kit

Europium Labeling Kit Europium Labeling Kit Catalog Number KA2096 100ug *1 Version: 03 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of the Assay...

More information

LDL Uptake Flow Cytometry Assay Kit

LDL Uptake Flow Cytometry Assay Kit LDL Uptake Flow Cytometry Assay Kit Item No. 601470 www.caymanchem.com Customer Service 800.364.9897 Technical Support 888.526.5351 1180 E. Ellsworth Rd Ann Arbor, MI USA TABLE OF CONTENTS GENERAL INFORMATION

More information

Disease causing organisms Resistance Immunity

Disease causing organisms Resistance Immunity Part 1 Disease causing organisms Resistance Immunity Bacteria Most common pathogens Anthrax Cholera Staphylococcus epidermidis bacteria Bacterial diseases Tuberculosis Cholera Bubonic Plague Tetanus Effects

More information

ANATOMY OF THE IMMUNE SYSTEM

ANATOMY OF THE IMMUNE SYSTEM Immunity Learning objectives Explain what triggers an immune response and where in the body the immune response occurs. Understand how the immune system handles exogenous and endogenous antigen differently.

More information

PRODUCT INFORMATION & MANUAL

PRODUCT INFORMATION & MANUAL PRODUCT INFORMATION & MANUAL 0.4 micron for Overall Exosome Isolation (Cell Media) NBP2-49826 For research use only. Not for diagnostic or therapeutic procedures. www.novusbio.com - P: 303.730.1950 - P:

More information

Macrophage Generation Media DXF

Macrophage Generation Media DXF Macrophage Generation Media DXF Instruction Manual Macrophage Generation Media DXF Product Size Catalog Number M1-Macrophage Generation Medium DXF 250 ml C-28055 M2-Macrophage Generation Medium DXF 250

More information

Topics. Humoral Immune Response Part II Accessory cells Fc Receptors Opsonization and killing mechanisms of phagocytes NK, mast, eosynophils

Topics. Humoral Immune Response Part II Accessory cells Fc Receptors Opsonization and killing mechanisms of phagocytes NK, mast, eosynophils Topics Humoral Immune Response Part II Accessory cells Fc Receptors Opsonization and killing mechanisms of phagocytes NK, mast, eosynophils Immune regulation Idiotypic network 2/15/2005 MICR 415 / 515

More information

(From The Rockefeller Uniuersitv, Neu) York 10021)

(From The Rockefeller Uniuersitv, Neu) York 10021) CHARACTERIZATION OF THE MACROPHAGE RECEPTOR FOR COMPLEMENT AND DEMONSTRATION OF ITS FUNCTIONAL INDEPENDENCE FROM THE RECEPTOR FOR THE Fc PORTION OF IMMUNOGLOBULIN G* BY FRANK M GRIFFIN, JR, CELSO BIANCO,

More information

Adaptive Immunity: Specific Defenses of the Host

Adaptive Immunity: Specific Defenses of the Host 17 Adaptive Immunity: Specific Defenses of the Host SLOs Differentiate between innate and adaptive immunity, and humoral and cellular immunity. Define antigen, epitope, and hapten. Explain the function

More information

THE QUANTITATIVE GLUCOSE AND MINERAL NUTRIENT REQUIREMENTS OF MOUSE LS (SUSPENSION) CELLS IN CHEMICALLY DEFINED MEDIUM

THE QUANTITATIVE GLUCOSE AND MINERAL NUTRIENT REQUIREMENTS OF MOUSE LS (SUSPENSION) CELLS IN CHEMICALLY DEFINED MEDIUM J. Cell Sci. 8, 693-700 (1971) Printed in Great Britain THE QUANTITATIVE GLUCOSE AND MINERAL NUTRIENT REQUIREMENTS OF MOUSE LS (SUSPENSION) CELLS IN CHEMICALLY DEFINED MEDIUM J. R. BIRCH* AND S. J. PIRT

More information

E. Histolytica IgG ELISA Kit

E. Histolytica IgG ELISA Kit E. Histolytica IgG ELISA Kit Catalog Number KA3193 96 assays Version: 01 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of

More information

PATHOGENS AND DEFENCE AGAINST INFECTIOUS DISEASE. By: Stephanie, Emily, Cem, and Julie

PATHOGENS AND DEFENCE AGAINST INFECTIOUS DISEASE. By: Stephanie, Emily, Cem, and Julie PATHOGENS AND DEFENCE AGAINST INFECTIOUS DISEASE By: Stephanie, Emily, Cem, and Julie Pathogen Pathogen: an organism or virus that causes a disease. Examples: bacteria, fungi, protozoa, virus Disease Cause

More information

DELFIA Tb-N1 DTA Chelate & Terbium Standard

DELFIA Tb-N1 DTA Chelate & Terbium Standard AD0029P-1 (en) 1 DELFIA Tb-N1 DTA Chelate & AD0012 Terbium Standard For Research Use Only INTRODUCTION DELFIA Tb-N1 DTA Chelate is optimized for the terbium labeling of proteins and peptides for use in

More information

Laboratory 10 Factors Controlling Phagocytosis in Tetrahymena,

Laboratory 10 Factors Controlling Phagocytosis in Tetrahymena, BIO354: Cell Biology Laboratory 1 Laboratory 1 Factors Controlling Phagocytosis in Tetrahymena, I. Introduction A characteristic feature of all eukaryotic cells is the ability to pinch off portions of

More information

FOR OPTIMAL GUT HEALTH KEMIN.COM/GUTHEALTH

FOR OPTIMAL GUT HEALTH KEMIN.COM/GUTHEALTH FOR OPTIMAL GUT HEALTH KEMIN.COM/GUTHEALTH ALETA A SOURCE OF 1,3-BETA GLUCANS Aleta is highly bioavailable, offering a concentration greater than 5% of 1,3-beta glucans. Aleta provides a consistent response

More information

Reagent Set DAS ELISA, Alkaline phosphatase label SRA 22001, SRA 23203, SRA 27703, SRA & SRA ToRSV, ArMV, GFLV, AnFBV and PDV

Reagent Set DAS ELISA, Alkaline phosphatase label SRA 22001, SRA 23203, SRA 27703, SRA & SRA ToRSV, ArMV, GFLV, AnFBV and PDV List of contents Lot number Reagent Set Item 96 wells 500 wells 1000 wells 5000 wells Capture antibody 0.150 ml 0.275 ml 0.525 ml 2.525 ml Alkaline phosphatase enzyme conjugate 0.150 ml 0.275 ml 0.525

More information

Introduction.-Cytopathogenic viruses may lose their cell-destroying capacity

Introduction.-Cytopathogenic viruses may lose their cell-destroying capacity AN INHIBITOR OF VIRAL ACTIVITY APPEARING IN INFECTED CELL CULTURES* BY MONTO Hot AND JOHN F. ENDERS RESEARCH DIVISION OF INFECTIOUS DISEASES, THE CHILDREN'S MEDICAL CENTER, AND THE DEPARTMENT OF BACTERIOLOGY

More information

ASSAY OF SPHINGOMYELINASE ACTIVITY

ASSAY OF SPHINGOMYELINASE ACTIVITY ASSAY OF SPHINGOMYELINASE ACTIVITY Protocol for Protein Extraction Stock Solution 1. Leupeptin/hydrochloride (FW 463.0,

More information

DELFIA Eu-DTPA ITC Chelate & Europium Standard

DELFIA Eu-DTPA ITC Chelate & Europium Standard AD0026P-3 (en) 1 DELFIA Eu-DTPA ITC Chelate & AD0021 Europium Standard For Research Use Only INTRODUCTION DELFIA Eu-DTPA ITC Chelate is optimized for the europium labelling of proteins and peptides for

More information

The Annexin V Apoptosis Assay

The Annexin V Apoptosis Assay The Annexin V Apoptosis Assay Development of the Annexin V Apoptosis Assay: 1990 Andree at al. found that a protein, Vascular Anticoagulant α, bound to phospholipid bilayers in a calcium dependent manner.

More information

Topics in Parasitology BLY Vertebrate Immune System

Topics in Parasitology BLY Vertebrate Immune System Topics in Parasitology BLY 533-2008 Vertebrate Immune System V. Vertebrate Immune System A. Non-specific defenses against pathogens 1. Skin - physical barrier a. Tough armor protein KERATIN b. Surface

More information

Astrovirus-associated gastroenteritis in children

Astrovirus-associated gastroenteritis in children Journal of Clinical Pathology, 1978, 31, 939-943 Astrovirus-associated gastroenteritis in children C. R. ASHLEY, E. 0. CAUL, AND W. K. PAVER1 From the Public Health Laboratory, Myrtle Road, Bristol BS2

More information

STUDIES OF THE HEMAGGLUTININ OF HAEMOPHILUS PERTUSSIS HIDEO FUKUMI, HISASHI SHIMAZAKI, SADAO KOBAYASHI AND TATSUJI UCHIDA

STUDIES OF THE HEMAGGLUTININ OF HAEMOPHILUS PERTUSSIS HIDEO FUKUMI, HISASHI SHIMAZAKI, SADAO KOBAYASHI AND TATSUJI UCHIDA STUDIES OF THE HEMAGGLUTININ OF HAEMOPHILUS PERTUSSIS HIDEO FUKUMI, HISASHI SHIMAZAKI, SADAO KOBAYASHI AND TATSUJI UCHIDA The National Institute of Health, Tokyo, Japan (Received: August 3rd, 1953) INTRODUCTION

More information

E.Z.N.A. SQ Blood DNA Kit II. Table of Contents

E.Z.N.A. SQ Blood DNA Kit II. Table of Contents E.Z.N.A. SQ Blood DNA Kit II Table of Contents Introduction and Overview...2 Kit Contents/Storage and Stability...3 Blood Storage and DNA Yield...4 Preparing Reagents...5 100-500 μl Whole Blood Protocol...6

More information

Essential Medium, containing 10% fetal bovine serum, 100 U/ml penicillin and 100 µg/ml streptomycin. Huvec were cultured in

Essential Medium, containing 10% fetal bovine serum, 100 U/ml penicillin and 100 µg/ml streptomycin. Huvec were cultured in Supplemental data Methods Cell culture media formulations A-431 and U-87 MG cells were maintained in Dulbecco s Modified Eagle s Medium. FaDu cells were cultured in Eagle's Minimum Essential Medium, containing

More information

Recipes for Media and Solution Preparation SC-ura/Glucose Agar Dishes (20mL/dish, enough for 8 clones)

Recipes for Media and Solution Preparation SC-ura/Glucose Agar Dishes (20mL/dish, enough for 8 clones) Protocol: 300 ml Yeast culture preparation Equipment and Reagents needed: Autoclaved toothpicks Shaker Incubator set at 30 C Incubator set at 30 C 60 mm 2 sterile petri dishes Autoclaved glass test tubes

More information

Radioimmunoassay of Herpes Simplex Virus Antibody: Correlation with Ganglionic Infection

Radioimmunoassay of Herpes Simplex Virus Antibody: Correlation with Ganglionic Infection J. gen. Virol. (I977), 3 6, ~ 371-375 Printed in Great Britain 371 Radioimmunoassay of Herpes Simplex Virus Antibody: Correlation with Ganglionic Infection By B. FORGHANI, TONI KLASSEN AND J. R. BARINGER

More information

(Anderson, 1946) containing sodium chloride, sodium-potassium phosphate. added to this basic medium in a concentration sufficient for maximum growth.

(Anderson, 1946) containing sodium chloride, sodium-potassium phosphate. added to this basic medium in a concentration sufficient for maximum growth. THE EFFECTS OF A TRYPTOPHAN-HISTIDINE DEFICIENCY IN A MUTANT OF ESCHERICHIA COLI MARGOT K. SANDS AND RICHARD B. ROBERTS Carnegie Institution of Washington, Department of Terrestrial Magnetism, Washington,

More information

Human Oxidized LDL ELISA Kit (MDA-LDL Quantitation), General

Human Oxidized LDL ELISA Kit (MDA-LDL Quantitation), General Human Oxidized LDL ELISA Kit (MDA-LDL Quantitation), General For the detection and quantitation of human OxLDL in plasma, serum or other biological fluid samples Cat. No. KT-959 For Research Use Only.

More information

Caution: For Laboratory Use. A product for research purposes only. Eu-W1284 Iodoacetamido Chelate & Europium Standard. Product Number: AD0014

Caution: For Laboratory Use. A product for research purposes only. Eu-W1284 Iodoacetamido Chelate & Europium Standard. Product Number: AD0014 TECHNICAL DATA SHEET Lance Caution: For Laboratory Use. A product for research purposes only. Eu-W1284 Iodoacetamido Chelate & Europium Standard Product Number: AD0014 INTRODUCTION: Iodoacetamido-activated

More information

The Immune System is the Third Line of Defense Against Infection. Components of Human Immune System

The Immune System is the Third Line of Defense Against Infection. Components of Human Immune System Chapter 17: Specific Host Defenses: The Immune Response The Immune Response Immunity: Free from burden. Ability of an organism to recognize and defend itself against specific pathogens or antigens. Immune

More information

Attachment and Ingestion Stages of Bacterial Phagocytosis

Attachment and Ingestion Stages of Bacterial Phagocytosis JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 1988, p. 62-66 0095-1137/88/010062-05$02.00/0 Copyright C 1988, American Society for Microbiology Vol. 26, No. 1 Enzyme-Linked Immunosorbent Assay for Quantitation

More information

PRODUCT: RNAzol BD for Blood May 2014 Catalog No: RB 192 Storage: Store at room temperature

PRODUCT: RNAzol BD for Blood May 2014 Catalog No: RB 192 Storage: Store at room temperature PRODUCT: RNAzol BD for Blood May 2014 Catalog No: RB 192 Storage: Store at room temperature PRODUCT DESCRIPTION. RNAzol BD is a reagent for isolation of total RNA from whole blood, plasma or serum of human

More information

NEUTROPHIL, BASOPHIL, EOSINOPHIL, AND PLATELETS SURFACE RECEPTORS

NEUTROPHIL, BASOPHIL, EOSINOPHIL, AND PLATELETS SURFACE RECEPTORS LECTURE: 15 Title NEUTROPHIL, BASOPHIL, EOSINOPHIL, AND PLATELETS SURFACE RECEPTORS LEARNING OBJECTIVES: The student should be able to: Determine the relative percentages in blood for the various types

More information

C. Incorrect! MHC class I molecules are not involved in the process of bridging in ADCC.

C. Incorrect! MHC class I molecules are not involved in the process of bridging in ADCC. Immunology - Problem Drill 13: T- Cell Mediated Immunity Question No. 1 of 10 1. During Antibody-dependent cell mediated cytotoxicity (ADCC), the antibody acts like a bridge between the specific antigen

More information

Caution: For Laboratory Use. A product for research purposes only. Eu-W1024 ITC Chelate & Europium Standard. Product Number: AD0013

Caution: For Laboratory Use. A product for research purposes only. Eu-W1024 ITC Chelate & Europium Standard. Product Number: AD0013 TECHNICAL DATA SHEET Lance Caution: For Laboratory Use. A product for research purposes only. Eu-W1024 ITC Chelate & Europium Standard Product Number: AD0013 INTRODUCTION: Fluorescent isothiocyanato-activated

More information

Temperature-Sensitive Mutants Isolated from Hamster and

Temperature-Sensitive Mutants Isolated from Hamster and JOURNAL OF VIROLOGY, Nov. 1975, p. 1332-1336 Copyright i 1975 American Society for Microbiology Vol. 16, No. 5 Printed in U.S.A. Temperature-Sensitive Mutants Isolated from Hamster and Canine Cell Lines

More information

Trichinella Cat #

Trichinella Cat # DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

Influenza A IgG ELISA

Influenza A IgG ELISA Influenza A IgG ELISA For the qualitative determination of IgG-class antibodies against Influenza A virus in human serum or plasma (citrate, heparin). For Research Use Only. Not For Use In Diagnostic Procedures.

More information

Host Defense Mechanisms Against Influenza Virus: Interaction of Influenza Virus with Murine Macrophages In Vitro

Host Defense Mechanisms Against Influenza Virus: Interaction of Influenza Virus with Murine Macrophages In Vitro INFECTION AND IMMUNITY, Dec. 1978, p. 758-762 0019-9567/78/0022-0758$02.00/0 Copyright 1978 American Society for Microbiology Vol. 22, No. 3 Printed in U.S.A. Host Defense Mechanisms Against Influenza

More information

Protocol for Gene Transfection & Western Blotting

Protocol for Gene Transfection & Western Blotting The schedule and the manual of basic techniques for cell culture Advanced Protocol for Gene Transfection & Western Blotting Schedule Day 1 26/07/2008 Transfection Day 3 28/07/2008 Cell lysis Immunoprecipitation

More information

psittaci by Silver-Methenamine Staining and

psittaci by Silver-Methenamine Staining and JOURNAL OF BACTERIOLOGY, July 1972, p. 267-271 Copyright 1972 American Society for Microbiology Vol. 111, No. 1 Printed in U.S.A. Location of Polysaccharide on Chlamydia psittaci by Silver-Methenamine

More information

Ch 12. Host Defenses I: Nonspecific Defenses

Ch 12. Host Defenses I: Nonspecific Defenses Ch 12 Host Defenses I: Nonspecific Defenses SLOs Differentiate between innate and adaptive immunity. Define and explain PRRs and PAMPs Differentiate physical from chemical factors, and list examples of

More information

Supplementary Files S1 Isolation of Monocytes S2 Haemolysis study Reagents Procedure S3 Cytotoxicity studies Trypan blue dye exclusion method

Supplementary Files S1 Isolation of Monocytes S2 Haemolysis study Reagents Procedure S3 Cytotoxicity studies Trypan blue dye exclusion method Electronic Supplementary Material (ESI) for RSC Advances. This journal is The Royal Society of Chemistry 2014 Supplementary Files S1 Isolation of Monocytes A 3 ml volume of Histopaque 1083 solution was

More information

Brief Definitive Report

Brief Definitive Report Brief Definitive Report HEMAGGLUTININ-SPECIFIC CYTOTOXIC T-CELL RESPONSE DURING INFLUENZA INFECTION BY FRANCIS A. ENNIS, W. JOHN MARTIN, ANY MARTHA W. VERBONITZ (From the Department of Health, Education

More information

E. Histolytica IgG (Amebiasis)

E. Histolytica IgG (Amebiasis) DIAGNOSTIC AUTOMATION, INC. 21250 Califa Street, Suite 102 and 116, Woodland hills, CA 91367 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com

More information

Please use only the valid version of the package insert provided with the kit.

Please use only the valid version of the package insert provided with the kit. Please use only the valid version of the package insert provided with the kit. Intended Use For the qualitative screening of serum IgG antibodies to Trichinella using an Enzyme Linked Immunoabsorbant Assay

More information

ANTIBODIES Jiri Mestecky, M.D., Ph.D. - Lecturer

ANTIBODIES Jiri Mestecky, M.D., Ph.D. - Lecturer ANTIBODIES Jiri Mestecky, M.D., Ph.D. - Lecturer Distribution in body fluids: secretions plasma (serum), tears, saliva, milk, genitourinary, and intestinal Cells producing antibodies and their tissue distribution:

More information

2009 H1N1 Influenza ( Swine Flu ) Hemagglutinin ELISA kit

2009 H1N1 Influenza ( Swine Flu ) Hemagglutinin ELISA kit 2009 H1N1 Influenza ( Swine Flu ) Hemagglutinin ELISA kit Catalog Number : SEK001 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as

More information

An Investigation into the Effects of the Addition of Synthetic Receptor on Chemokine Induced Jurkat T-Cell Migration

An Investigation into the Effects of the Addition of Synthetic Receptor on Chemokine Induced Jurkat T-Cell Migration An Investigation into the Effects of the Addition of Synthetic Receptor on Chemokine Induced Jurkat T-Cell Migration Jessica Jurado, Jianfang Hu, Avery August, PhD PSU Undergraduate Animal Bioscience July

More information

CELL MEDIATED IMMUNE RESPONSE

CELL MEDIATED IMMUNE RESPONSE CELL MEDIATED IMMUNE RESPONSE Chapter IV - CELL MEDIATED IMMUNE RESPONSE Sujatha, M. 2013. Evaluation of Immunological changes in Fish, Catla catla administered with bacterial pathogen, Aeromonas hydrophila,

More information

Study of the One-Step Growth Curve of Equine Infectious Anemia Virus by Immunofluorescence

Study of the One-Step Growth Curve of Equine Infectious Anemia Virus by Immunofluorescence INFECTION AND IMMUNITY, June 1972, p. 89-895 Copyright 1972 American Society for Microbiology Vol. 5, No. 6 Printed in U.S.A Study of the One-Step Growth Curve of Equine Infectious Anemia Virus by Immunofluorescence

More information

Use of the own platelet plasma in the treatment of chronic inflammatory conditions of the skin

Use of the own platelet plasma in the treatment of chronic inflammatory conditions of the skin Dr. V.V.Bulat Use of the own platelet plasma in the treatment of chronic inflammatory conditions of the skin The chronic inflammatory diseases play an important role in the structure of the skin diseases

More information

Identification of the Virucidal Agent in Wastewater Sludge

Identification of the Virucidal Agent in Wastewater Sludge APPLIED AND ENVIRONMENTAL MICROBIOLOGY, Apr. 1977, p. 860-864 Copyright X) 1977 American Society for Microbiology Vol. 33, No. 4 Printed in U.S.A. Identification of the Virucidal Agent in Wastewater Sludge

More information

DELFIA Tb-DTPA ITC Chelate & Terbium Standard

DELFIA Tb-DTPA ITC Chelate & Terbium Standard AD0035P-2 (en) 1 DELFIA Tb-DTPA ITC Chelate & AD0029 Terbium Standard For Research Use Only INTRODUCTION DELFIA Tb-DTPA ITC Chelate is optimized for the terbium labelling of proteins and peptides for use

More information

Defense mechanism against pathogens

Defense mechanism against pathogens Defense mechanism against pathogens Immune System What is immune system? Cells and organs within an animal s body that contribute to immune defenses against pathogens ( ) Bacteria -Major entry points ;open

More information

Mouse Leptin ELISA Kit Instructions

Mouse Leptin ELISA Kit Instructions V.6/Mar/2008 CRYSTAL CHEM INC. Mouse Leptin ELISA Kit Instructions For the quantitative determination of leptin in mouse serum or plasma and fluid Catalog #: 90030 96 Assays For Research Use Only. Not

More information

PART A. True/False. Indicate in the space whether each of the following statements are true or false.

PART A. True/False. Indicate in the space whether each of the following statements are true or false. MCB 55 Plagues and Pandemics Midterm I Practice questions Read each question carefully. All the questions can be answered briefly, in the space allotted. PART A. True/False. Indicate in the space whether

More information

Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University

Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University Medical Virology Immunology Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University Human blood cells Phases of immune responses Microbe Naïve

More information

Anti-infectious Immunity

Anti-infectious Immunity Anti-infectious Immunity innate immunity barrier structures Secretory molecules Phagocytes NK cells Anatomical barriers 1. Skin and mucosa barrier 2.hemo-Spinal Fluid barrier 3. placental barrier Phagocytic

More information

Animal model for testing human Ascaris allergens

Animal model for testing human Ascaris allergens J. Biosci., Vol. 3 Number 1, March 1981, pp. 77-82. Printed in India. Animal model for testing human Ascaris allergens KRISHNA MUKERJI*, R. P. SAXENA, S. N. GHATAK and K. C. SAXENA Division of Biochemistry,

More information

J07 Titer dynamics, complement fixation test and neutralization tests

J07 Titer dynamics, complement fixation test and neutralization tests avllm0421c (spring 2017) J07 Titer dynamics, complement fixation test and neutralization tests Outline titer, antibody titer dynamics complement, complement fixation reaction neutralization tests 2/35

More information

Optimization of the Fuse-It-mRNA Protocol for L929 Cells in the µ-plate 24 Well

Optimization of the Fuse-It-mRNA Protocol for L929 Cells in the µ-plate 24 Well Optimization of the Fuse-It-mRNA Protocol for L929 Cells in the µ-plate 24 Well 1. General Information... 1 2. Background... 1 3. Material and Equipment Required... 2 4. Experimental Procedure and Results...

More information

ELECTRON MICROSCOPIC STUDIES ON EQUINE ENCEPHALOSIS VIRUS

ELECTRON MICROSCOPIC STUDIES ON EQUINE ENCEPHALOSIS VIRUS Onderstepoort]. vet. Res. 40 (2), 53-58 (1973) ELECTRON MICROSCOPIC STUDIES ON EQUINE ENCEPHALOSIS VIRUS G. LECATSAS, B. J. ERASMUS and H. J. ELS, Veterinary Research Institute, Onderstepoort ABSTRACT

More information

Role of Interferon in the Propagation of MM Virus in L Cells

Role of Interferon in the Propagation of MM Virus in L Cells APPLIED MICROBIOLOGY, Oct. 1969, p. 584-588 Copyright ( 1969 American Society for Microbiology Vol. 18, No. 4 Printed in U S A. Role of Interferon in the Propagation of MM Virus in L Cells DAVID J. GIRON

More information

Ultrastructural Study of Human Natural Killer CNK) Cell*)

Ultrastructural Study of Human Natural Killer CNK) Cell*) Hiroshima Journal of Medical Sciences Vol. 31, No. 1, March, 1982 HJIM 31-6 31 Ultrastructural Study of Human Natural Killer CNK) Cell*) Yoshinori KAWAGUCHI, Eishi KITTAKA, Yoshito TANAKA, Takeo TANAKA

More information